146 related articles for article (PubMed ID: 12108031)
21. The oestrogen-progesterone receptor ratio: an indicator of breast cancer evolution.
Cherubini M; Baxa P; Guarino G
Chir Ital; 2002; 54(4):423-8. PubMed ID: 12239750
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of hormone receptors in breast cancer.
Koenig K
Mt Sinai J Med; 1988 Mar; 55(2):207-10. PubMed ID: 3260349
[No Abstract] [Full Text] [Related]
23. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
[TBL] [Abstract][Full Text] [Related]
24. [Steroid hormone receptors in breast cancer (a review of the literature)].
Korolev VI; Dziubko NIa; Tarutinov VI
Vrach Delo; 1988 Nov; (11):86-91. PubMed ID: 2853492
[No Abstract] [Full Text] [Related]
25. [Immunohistochemical analysis of hormonal receptors in cancer of the breast. Current evaluation].
Jacquemier J; Hassoun J; Martin PM
Ann Pathol; 1989; 9(3):165-9. PubMed ID: 2667531
[No Abstract] [Full Text] [Related]
26. The usefulness of steroid hormone receptors in the management of primary and advanced breast cancer.
McGuire WL
Eur J Cancer (1965); 1980; Suppl 1():39-43. PubMed ID: 7032943
[No Abstract] [Full Text] [Related]
27. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
[TBL] [Abstract][Full Text] [Related]
28. Age interacts with the expression of steroid and HER-2 receptors in operable invasive breast cancer.
Neven P; Van Calster B; Van den Bempt I; Van Huffel S; Van Belle V; Hendrickx W; Decock J; Wildiers H; Paridaens R; Amant F; Leunen K; Berteloot P; Timmerman D; Van Limbergen E; Weltens C; Van den Bogaert W; Smeets A; Vergote I; Christiaens MR; Drijkoningen M
Breast Cancer Res Treat; 2008 Jul; 110(1):153-9. PubMed ID: 17687649
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer and neoadjuvant therapy: any predictive marker?
Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
[TBL] [Abstract][Full Text] [Related]
30. Clinical aspects of steroid receptor assays.
Leake RE
Med Lab Sci; 1984 Jul; 41(3):257-61. PubMed ID: 6482693
[No Abstract] [Full Text] [Related]
31. From conventional pathologic diagnosis to the molecular classification of breast carcinoma: are we ready for the change?
Raica M; Jung I; Cîmpean AM; Suciu C; Mureşan AM
Rom J Morphol Embryol; 2009; 50(1):5-13. PubMed ID: 19221640
[TBL] [Abstract][Full Text] [Related]
32. [Clinical-diagnostic significance of steroid hormone receptor determinations].
Martin R; Rotzsch W
Z Gesamte Inn Med; 1991 Apr; 46(5):150-5. PubMed ID: 1648850
[TBL] [Abstract][Full Text] [Related]
33. [Steroid receptors and NK cell activity in patients with breast cancer].
Konjević G; Branković-Magić M; Nikolić-Vukosavljević D; Spuzić I
Srp Arh Celok Lek; 1994; 122(5-6):139-42. PubMed ID: 17977410
[TBL] [Abstract][Full Text] [Related]
34. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
35. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
36. Hormone receptors in defining breast cancer prognosis--time for a rethink?
Speirs V; Shaaban AM
Nat Clin Pract Oncol; 2007 Apr; 4(4):204-5. PubMed ID: 17392711
[No Abstract] [Full Text] [Related]
37. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
38. Time for reappraisal of progesterone-receptor testing in breast cancer management.
MacGrogan G; de Mascarel I; Sierankowski G; Mauriac L; Debled M; Durand M; De Lara CT; Avril A; Picot V; Mathoulin-Pélissier S
J Clin Oncol; 2005 Apr; 23(12):2870-1; author reply 2871. PubMed ID: 15838009
[No Abstract] [Full Text] [Related]
39. [Prognostic and predictive factors in breast cancer].
Bozhok AA; Semiglazov VF; Semiglazov VV; Arzumanov AS; Klettsel' AE
Vopr Onkol; 2005; 51(4):434-43. PubMed ID: 16308974
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of hormone receptor in breast cancers and the prognosis].
Date Y; Horii R; Akiyama F
Nihon Rinsho; 2007 Jun; 65 Suppl 6():555-8. PubMed ID: 17682210
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
